Human Flt3L generates dendritic cells from canine peripheral blood precursors: Implications for a dog glioma clinical trial

Weidong Xiong, Marianela Candolfi, Chunyan Liu, A. K M Ghulam Muhammad, Kader Yagiz, Mariana Puntel, Peter F Moore, Julie Avalos, John D. Young, Dorothy Khan, Randy Donelson, G. Elizabeth Pluhar, John R. Ohlfest, Kolja Wawrowsky, Pedro R. Lowenstein, Maria G. Castro

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Background: Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and carries a dismal prognosis. We have developed a conditional cytotoxic/immunotherapeutic approach using adenoviral vectors (Ads) encoding the immunostimulatory cytokine, human soluble fms-like tyrosine kinase 3 ligand (hsFlt3L) and the conditional cytotoxic molecule, i.e., Herpes Simplex Type 1- thymide kinase (TK). This therapy triggers an anti-tumor immune response that leads to tumor regression and anti-tumor immunological memory in intracranial rodent cancer models. We aim to test the efficacy of this immunotherapy in dogs bearing spontaneous GBM. In view of the controversy regarding the effect of human cytokines on dog immune cells, and considering that the efficacy of this treatment depends on hsFlt3L-stimulated dendritic cells (DCs), in the present work we tested the ability of Ad-encoded hsFlt3L to generate DCs from dog peripheral blood and compared its effects with canine IL-4 and GM-CSF. Methodology/Principal Findings: Our results demonstrate that hsFlT3L expressed form an Ad vector, generated DCs from peripheral blood cultures with very similar morphological and phenotypic characteristics to canine IL-4 and GM-CSFcultured DCs. These include phagocytic activity and expression of CD11c, MHCII, CD80 and CD14. Maturation of DCs cultured under both conditions resulted in increased secretion of IL-6, TNF-a and IFN-c. Importantly, hsFlt3L-derived antigen presenting cells showed allostimulatory potential highlighting their ability to present antigen to T cells and elicit their proliferation. Conclusions/Significance: These results demonstrate that hsFlt3L induces the proliferation of canine DCs and support its use in upcoming clinical trials for canine GBM. Our data further support the translation of hsFlt3L to be used for dendritic cells' vaccination and gene therapeutic approaches from rodent models to canine patients and its future implementation in human clinical trials.

Original languageEnglish (US)
Article numbere11074
JournalPLoS One
Volume5
Issue number6
DOIs
StatePublished - 2010

Fingerprint

dendritic cells
Glioma
Dendritic Cells
Canidae
clinical trials
Blood
Clinical Trials
phosphotransferases (kinases)
Dogs
tyrosine
dogs
blood
Tumors
Glioblastoma
neoplasms
Interleukin-4
interleukin-4
Bearings (structural)
Rodentia
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Xiong, W., Candolfi, M., Liu, C., Ghulam Muhammad, A. K. M., Yagiz, K., Puntel, M., ... Castro, M. G. (2010). Human Flt3L generates dendritic cells from canine peripheral blood precursors: Implications for a dog glioma clinical trial. PLoS One, 5(6), [e11074]. https://doi.org/10.1371/journal.pone.0011074

Human Flt3L generates dendritic cells from canine peripheral blood precursors : Implications for a dog glioma clinical trial. / Xiong, Weidong; Candolfi, Marianela; Liu, Chunyan; Ghulam Muhammad, A. K M; Yagiz, Kader; Puntel, Mariana; Moore, Peter F; Avalos, Julie; Young, John D.; Khan, Dorothy; Donelson, Randy; Pluhar, G. Elizabeth; Ohlfest, John R.; Wawrowsky, Kolja; Lowenstein, Pedro R.; Castro, Maria G.

In: PLoS One, Vol. 5, No. 6, e11074, 2010.

Research output: Contribution to journalArticle

Xiong, W, Candolfi, M, Liu, C, Ghulam Muhammad, AKM, Yagiz, K, Puntel, M, Moore, PF, Avalos, J, Young, JD, Khan, D, Donelson, R, Pluhar, GE, Ohlfest, JR, Wawrowsky, K, Lowenstein, PR & Castro, MG 2010, 'Human Flt3L generates dendritic cells from canine peripheral blood precursors: Implications for a dog glioma clinical trial', PLoS One, vol. 5, no. 6, e11074. https://doi.org/10.1371/journal.pone.0011074
Xiong, Weidong ; Candolfi, Marianela ; Liu, Chunyan ; Ghulam Muhammad, A. K M ; Yagiz, Kader ; Puntel, Mariana ; Moore, Peter F ; Avalos, Julie ; Young, John D. ; Khan, Dorothy ; Donelson, Randy ; Pluhar, G. Elizabeth ; Ohlfest, John R. ; Wawrowsky, Kolja ; Lowenstein, Pedro R. ; Castro, Maria G. / Human Flt3L generates dendritic cells from canine peripheral blood precursors : Implications for a dog glioma clinical trial. In: PLoS One. 2010 ; Vol. 5, No. 6.
@article{01608f77606f47d3b6ef1e85ce80373c,
title = "Human Flt3L generates dendritic cells from canine peripheral blood precursors: Implications for a dog glioma clinical trial",
abstract = "Background: Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and carries a dismal prognosis. We have developed a conditional cytotoxic/immunotherapeutic approach using adenoviral vectors (Ads) encoding the immunostimulatory cytokine, human soluble fms-like tyrosine kinase 3 ligand (hsFlt3L) and the conditional cytotoxic molecule, i.e., Herpes Simplex Type 1- thymide kinase (TK). This therapy triggers an anti-tumor immune response that leads to tumor regression and anti-tumor immunological memory in intracranial rodent cancer models. We aim to test the efficacy of this immunotherapy in dogs bearing spontaneous GBM. In view of the controversy regarding the effect of human cytokines on dog immune cells, and considering that the efficacy of this treatment depends on hsFlt3L-stimulated dendritic cells (DCs), in the present work we tested the ability of Ad-encoded hsFlt3L to generate DCs from dog peripheral blood and compared its effects with canine IL-4 and GM-CSF. Methodology/Principal Findings: Our results demonstrate that hsFlT3L expressed form an Ad vector, generated DCs from peripheral blood cultures with very similar morphological and phenotypic characteristics to canine IL-4 and GM-CSFcultured DCs. These include phagocytic activity and expression of CD11c, MHCII, CD80 and CD14. Maturation of DCs cultured under both conditions resulted in increased secretion of IL-6, TNF-a and IFN-c. Importantly, hsFlt3L-derived antigen presenting cells showed allostimulatory potential highlighting their ability to present antigen to T cells and elicit their proliferation. Conclusions/Significance: These results demonstrate that hsFlt3L induces the proliferation of canine DCs and support its use in upcoming clinical trials for canine GBM. Our data further support the translation of hsFlt3L to be used for dendritic cells' vaccination and gene therapeutic approaches from rodent models to canine patients and its future implementation in human clinical trials.",
author = "Weidong Xiong and Marianela Candolfi and Chunyan Liu and {Ghulam Muhammad}, {A. K M} and Kader Yagiz and Mariana Puntel and Moore, {Peter F} and Julie Avalos and Young, {John D.} and Dorothy Khan and Randy Donelson and Pluhar, {G. Elizabeth} and Ohlfest, {John R.} and Kolja Wawrowsky and Lowenstein, {Pedro R.} and Castro, {Maria G.}",
year = "2010",
doi = "10.1371/journal.pone.0011074",
language = "English (US)",
volume = "5",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "6",

}

TY - JOUR

T1 - Human Flt3L generates dendritic cells from canine peripheral blood precursors

T2 - Implications for a dog glioma clinical trial

AU - Xiong, Weidong

AU - Candolfi, Marianela

AU - Liu, Chunyan

AU - Ghulam Muhammad, A. K M

AU - Yagiz, Kader

AU - Puntel, Mariana

AU - Moore, Peter F

AU - Avalos, Julie

AU - Young, John D.

AU - Khan, Dorothy

AU - Donelson, Randy

AU - Pluhar, G. Elizabeth

AU - Ohlfest, John R.

AU - Wawrowsky, Kolja

AU - Lowenstein, Pedro R.

AU - Castro, Maria G.

PY - 2010

Y1 - 2010

N2 - Background: Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and carries a dismal prognosis. We have developed a conditional cytotoxic/immunotherapeutic approach using adenoviral vectors (Ads) encoding the immunostimulatory cytokine, human soluble fms-like tyrosine kinase 3 ligand (hsFlt3L) and the conditional cytotoxic molecule, i.e., Herpes Simplex Type 1- thymide kinase (TK). This therapy triggers an anti-tumor immune response that leads to tumor regression and anti-tumor immunological memory in intracranial rodent cancer models. We aim to test the efficacy of this immunotherapy in dogs bearing spontaneous GBM. In view of the controversy regarding the effect of human cytokines on dog immune cells, and considering that the efficacy of this treatment depends on hsFlt3L-stimulated dendritic cells (DCs), in the present work we tested the ability of Ad-encoded hsFlt3L to generate DCs from dog peripheral blood and compared its effects with canine IL-4 and GM-CSF. Methodology/Principal Findings: Our results demonstrate that hsFlT3L expressed form an Ad vector, generated DCs from peripheral blood cultures with very similar morphological and phenotypic characteristics to canine IL-4 and GM-CSFcultured DCs. These include phagocytic activity and expression of CD11c, MHCII, CD80 and CD14. Maturation of DCs cultured under both conditions resulted in increased secretion of IL-6, TNF-a and IFN-c. Importantly, hsFlt3L-derived antigen presenting cells showed allostimulatory potential highlighting their ability to present antigen to T cells and elicit their proliferation. Conclusions/Significance: These results demonstrate that hsFlt3L induces the proliferation of canine DCs and support its use in upcoming clinical trials for canine GBM. Our data further support the translation of hsFlt3L to be used for dendritic cells' vaccination and gene therapeutic approaches from rodent models to canine patients and its future implementation in human clinical trials.

AB - Background: Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and carries a dismal prognosis. We have developed a conditional cytotoxic/immunotherapeutic approach using adenoviral vectors (Ads) encoding the immunostimulatory cytokine, human soluble fms-like tyrosine kinase 3 ligand (hsFlt3L) and the conditional cytotoxic molecule, i.e., Herpes Simplex Type 1- thymide kinase (TK). This therapy triggers an anti-tumor immune response that leads to tumor regression and anti-tumor immunological memory in intracranial rodent cancer models. We aim to test the efficacy of this immunotherapy in dogs bearing spontaneous GBM. In view of the controversy regarding the effect of human cytokines on dog immune cells, and considering that the efficacy of this treatment depends on hsFlt3L-stimulated dendritic cells (DCs), in the present work we tested the ability of Ad-encoded hsFlt3L to generate DCs from dog peripheral blood and compared its effects with canine IL-4 and GM-CSF. Methodology/Principal Findings: Our results demonstrate that hsFlT3L expressed form an Ad vector, generated DCs from peripheral blood cultures with very similar morphological and phenotypic characteristics to canine IL-4 and GM-CSFcultured DCs. These include phagocytic activity and expression of CD11c, MHCII, CD80 and CD14. Maturation of DCs cultured under both conditions resulted in increased secretion of IL-6, TNF-a and IFN-c. Importantly, hsFlt3L-derived antigen presenting cells showed allostimulatory potential highlighting their ability to present antigen to T cells and elicit their proliferation. Conclusions/Significance: These results demonstrate that hsFlt3L induces the proliferation of canine DCs and support its use in upcoming clinical trials for canine GBM. Our data further support the translation of hsFlt3L to be used for dendritic cells' vaccination and gene therapeutic approaches from rodent models to canine patients and its future implementation in human clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=77956211427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956211427&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0011074

DO - 10.1371/journal.pone.0011074

M3 - Article

C2 - 20552015

AN - SCOPUS:77956211427

VL - 5

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 6

M1 - e11074

ER -